Analysts forecast that U.S. Physical Therapy, Inc. (NYSE:USPH) will announce $102.69 million in sales for the current quarter, Zacks reports. Two analysts have made estimates for U.S. Physical Therapy’s earnings, with the lowest sales estimate coming in at $100.25 million and the highest estimate coming in at $105.13 million. U.S. Physical Therapy reported sales of $88.34 million during the same quarter last year, which would suggest a positive year over year growth rate of 16.2%. The firm is expected to issue its next quarterly earnings results on Thursday, November 2nd.
According to Zacks, analysts expect that U.S. Physical Therapy will report full year sales of $102.69 million for the current fiscal year, with estimates ranging from $404.13 million to $416.54 million. For the next fiscal year, analysts forecast that the firm will report sales of $446.83 million per share, with estimates ranging from $437.53 million to $456.13 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that cover U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.60 by $0.01. U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. The business had revenue of $104.25 million for the quarter, compared to analyst estimates of $102.93 million.
Several research analysts have weighed in on USPH shares. Zacks Investment Research cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Wednesday, June 21st. Barrington Research upgraded U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price objective on the stock in a research report on Monday, July 3rd. Jefferies Group LLC reiterated a “hold” rating and set a $63.00 price objective on shares of U.S. Physical Therapy in a research report on Friday, June 30th. Cantor Fitzgerald started coverage on U.S. Physical Therapy in a research report on Monday, July 24th. They set an “overweight” rating and a $72.00 price objective on the stock. Finally, BidaskClub cut U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research report on Sunday, July 16th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $68.50.
WARNING: “Brokerages Anticipate U.S. Physical Therapy, Inc. (NYSE:USPH) Will Announce Quarterly Sales of $102.69 Million” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://www.com-unik.info/2017/08/12/brokerages-anticipate-u-s-physical-therapy-inc-nyseusph-will-announce-quarterly-sales-of-102-69-million.html.
In related news, Director Bernard A. Harris, Jr. sold 5,000 shares of the firm’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $62.00, for a total value of $310,000.00. Following the transaction, the director now owns 26,422 shares in the company, valued at $1,638,164. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.30% of the stock is currently owned by company insiders.
A number of hedge funds have recently added to or reduced their stakes in USPH. Dimensional Fund Advisors LP raised its stake in U.S. Physical Therapy by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 486,775 shares of the company’s stock valued at $29,401,000 after buying an additional 3,853 shares during the period. Citadel Advisors LLC raised its stake in U.S. Physical Therapy by 22.6% in the second quarter. Citadel Advisors LLC now owns 9,147 shares of the company’s stock valued at $552,000 after buying an additional 1,689 shares during the period. Renaissance Technologies LLC raised its stake in U.S. Physical Therapy by 10.4% in the second quarter. Renaissance Technologies LLC now owns 668,074 shares of the company’s stock valued at $40,352,000 after buying an additional 63,074 shares during the period. ETRADE Capital Management LLC raised its stake in U.S. Physical Therapy by 16.9% in the second quarter. ETRADE Capital Management LLC now owns 6,301 shares of the company’s stock valued at $381,000 after buying an additional 911 shares during the period. Finally, Vanguard Group Inc. raised its stake in U.S. Physical Therapy by 2.2% in the second quarter. Vanguard Group Inc. now owns 655,524 shares of the company’s stock valued at $39,594,000 after buying an additional 13,991 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.
Shares of U.S. Physical Therapy (NYSE USPH) opened at 61.70 on Friday. The firm has a market cap of $776.25 million, a P/E ratio of 39.05 and a beta of 1.06. U.S. Physical Therapy has a 1-year low of $51.96 and a 1-year high of $78.00. The firm’s 50-day moving average is $62.62 and its 200-day moving average is $66.06.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 8th. Investors of record on Monday, August 21st will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date of this dividend is Thursday, August 17th. U.S. Physical Therapy’s payout ratio is currently 46.78%.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about U.S. Physical Therapy Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for U.S. Physical Therapy Inc. and related companies.